Methyl 4-[(6-bromo-3-methyl-2-thiophen-2-ylquinoline-4-carbonyl)amino]bicyclo[2.2.2]octane-1-carboxylate
C25H25BrN2O3S — CID 122551192
Data last refreshed: (MolForge compound catalog, from PubChem)
About Methyl 4-[(6-bromo-3-methyl-2-thiophen-2-ylquinoline-4-carbonyl)amino]bicyclo[2.2.2]octane-1-carboxylate
Methyl 4-[(6-bromo-3-methyl-2-thiophen-2-ylquinoline-4-carbonyl)amino]bicyclo[2.2.2]octane-1-carboxylate (PubChem CID 122551192) has the molecular formula C25H25BrN2O3S and a molecular weight of 513.46 g/mol. Its IUPAC name is methyl 4-[(6-bromo-3-methyl-2-thiophen-2-ylquinoline-4-carbonyl)amino]bicyclo[2.2.2]octane-1-carboxylate.
Molecular Properties
| Compound Name | Methyl 4-[(6-bromo-3-methyl-2-thiophen-2-ylquinoline-4-carbonyl)amino]bicyclo[2.2.2]octane-1-carboxylate |
|---|---|
| PubChem CID | 122551192 |
| Molecular Formula | C25H25BrN2O3S |
| Molecular Weight | 513.46 g/mol |
| Exact Mass | 512.08 |
| IUPAC Name | methyl 4-[(6-bromo-3-methyl-2-thiophen-2-ylquinoline-4-carbonyl)amino]bicyclo[2.2.2]octane-1-carboxylate |
| SMILES | COC(=O)C12CCC(NC(=O)c3c(C)c(-c4cccs4)nc4ccc(Br)cc34)(CC1)CC2 |
| InChI | InChI=1S/C25H25BrN2O3S/c1-15-20(17-14-16(26)5-6-18(17)27-21(15)19-4-3-13-32-19)22(29)28-25-10-7-24(8-11-25,9-12-25)23(30)31-2/h3-6,13-14H,7-12H2,1-2H3,(H,28,29) |
| InChIKey | WGBMNLYQCXMUNJ-UHFFFAOYSA-N |
| XLogP | 6.03 |
| TPSA | 68.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 513.46 |
| LogP ≤ 5 | 6.03 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 122551192 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.